Evaluation of IPO Price-Evidence from Taiwanese Biotechnology Companies

碩士 === 國立臺灣大學 === 財務金融學研究所 === 106 === Biotechnology industry being highly professional with high proportion of intangible assets possession makes it difficult to be priced accurately. This paper target on biotechnology company Initial Public Offerings pricing. Substitute negative cash flow with cer...

Full description

Bibliographic Details
Main Authors: Peng-Yu Chen, 陳芃瑀
Other Authors: 姜堯民
Format: Others
Language:zh-TW
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/zzp29g